DPEP1 and kidney disorder: Finally, CRISPR genome editing established the functional impact of these regions, demonstrating that deleting distinct peaks (e.g., peaks 8 and 9 for DPEP1 and peaks 8 and 12 for CHMP1A) directly and specifically altered the expression of each gene, thereby validating their roles as key effector genes in kidney disease.